Additionally, using an HFD-induced mouse obesity model to investigate the effects of SGLT2 inhibitors, we found changes in the expression of AgRP and POMC mRNA depending on the duration of SGLT2 inhibitor treatment. The gene discussed is AGRP; the disease is obesity due to melanocortin 4 receptor deficiency.